US Patent 10377750 5-methyl-1,3,4-oxadiazol-2-yl compounds
Patent 10377750 was granted and assigned to Eli Lilly and Company on August, 2019 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 10377750 5-methyl-1,3,4-oxadiazol-2-yl compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
